Rankings
▼
Calendar
VTYX (Ventyx Biosciences, Inc.) Stock Financials & Earnings | Market Cap Arena
VTYX
Ventyx Biosciences, Inc.
Mkt Cap
$1B
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$0
Net Income (TTM)
-$107M
EPS (TTM)
-$1.50
Free Cash Flow (TTM)
-$88M
Gross Margin
—
Op. Margin
—
Net Margin
—
FCF Margin
—
P/S Ratio (TTM)
—
P/E Ratio (TTM)
—
YoY Rev Growth
—
Employees
—
Earnings Reports
▶
Q3 2025
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q4 22
$0
$0
-$39M
Q1 23
$0
$0
-$43M
Q2 23
$0
$0
-$57M
Q3 23
$0
$0
-$58M
Q4 23
$0
$0
-$50M
Q1 24
$0
-$408K
-$42M
Q2 24
$0
-$316K
-$36M
Q3 24
$0
$0
-$39M
Q4 24
$0
$0
-$32M
Q1 25
$0
$0
-$30M
Q2 25
$0
$0
-$29M
Q3 25
$0
$0
-$25M
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q4 22
-$47M
-$47M
Q1 23
-$31M
-$31M
Q2 23
-$49M
-$49M
Q3 23
-$35M
-$35M
Q4 23
-$52M
-$52M
Q1 24
-$48M
-$48M
Q2 24
-$25M
-$25M
Q3 24
-$35M
-$35M
Q4 24
-$23M
-$23M
Q1 25
-$26M
-$26M
Q2 25
-$21M
-$21M
Q3 25
-$18M
-$18M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q4 22
$112K
Q1 23
$60K
Q2 23
$195K
Q3 23
$48K
Q4 23
$211K
Q1 24
$175K
Q2 24
$60K
Q3 24
$0
Q4 24
$6K
Q1 25
$16K
Q2 25
$42K
Q3 25
$50K
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q4 22
—
+116.4%
Q1 23
—
+87.1%
Q2 23
—
+180.2%
Q3 23
—
+84.4%
Q4 23
—
+30.5%
Q1 24
—
-1.8%
Q2 24
—
-37.5%
Q3 24
—
-33.5%
Q4 24
—
-35.6%
Q1 25
—
-27.9%
Q2 25
—
-17.9%
Q3 25
—
-35.5%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q4 22
$5M
—
Q1 23
$7M
—
Q2 23
$8M
—
Q3 23
$8M
—
Q4 23
$6M
—
Q1 24
$7M
—
Q2 24
$6M
—
Q3 24
$5M
—
Q4 24
$5M
—
Q1 25
$5M
—
Q2 25
$5M
—
Q3 25
$5M
—
marketcaparena.com
OpEx Breakdown
R&D
G&A
Quarter
R&D
G&A
Q4 22
$30M
$8M
Q1 23
$35M
$7M
Q2 23
$49M
$9M
Q3 23
$50M
$8M
Q4 23
$42M
$8M
Q1 24
$34M
$8M
Q2 24
$28M
$8M
Q3 24
$31M
$8M
Q4 24
$25M
$8M
Q1 25
$23M
$7M
Q2 25
$22M
$7M
Q3 25
$18M
$7M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q4 22
$65M
$253M
$318M
Q1 23
$64M
$313M
$377M
Q2 23
$52M
$281M
$332M
Q3 23
$57M
$244M
$301M
Q4 23
$52M
$201M
$252M
Q1 24
$142M
$161M
$303M
Q2 24
$41M
$199M
$239M
Q3 24
$62M
$213M
$275M
Q4 24
$27M
$190M
$217M
Q1 25
$28M
$201M
$229M
Q2 25
$32M
$177M
$209M
Q3 25
$32M
$161M
$193M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q4 22
57M
+9.8%
Q1 23
58M
+1.6%
Q2 23
59M
+1.6%
Q3 23
59M
+0.6%
Q4 23
59M
+0.3%
Q1 24
62M
+4.7%
Q2 24
71M
+14.1%
Q3 24
71M
+0.2%
Q4 24
71M
+0.2%
Q1 25
71M
+0.5%
Q2 25
71M
+0.1%
Q3 25
71M
+0.1%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 19
—
—
FY 20
—
—
FY 21
$0
27
FY 22
$0
58
FY 23
$0
79
FY 24
$0
79
marketcaparena.com